TrianglePUBLICATIONS · 36206505
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Jan 20
- First author
- Lerman BJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Lerman BJ
- type
- Author
- name
- Li Y
- type
- Author
- name
- Carlowicz C
- type
- Author
- name
- Granger M
- type
- Author
- name
- Cash T
- type
- Author
- name
- Sadanand A
- type
- Author
- name
- Somers K
- type
- Author
- name
- Ranavaya A
- type
- Author
- name
- Weiss BD
- type
- Author
- name
- Choe M
- type
- Author
- name
- Foster JH
- type
- Author
- name
- Pinto N
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Lerman BJ
- type
- Author
- name
- Li Y
- type
- Author
- name
- Carlowicz C
- type
- Author
- name
- Granger M
- type
- Author
- name
- Cash T
- type
- Author
- name
- Sadanand A
- type
- Author
- name
- Somers K
- type
- Author
- name
- Ranavaya A
- type
- Author
- name
- Weiss BD
- type
- Author
- name
- Choe M
- type
- Author
- name
- Foster JH
- type
- Author
- name
- Pinto N
- type
- Author
- bibliography ids
- nci-bib-343ddc157e6474a8cfabe692
- book metadata
- content sha256
- 11fc9a96eaa32971f84b3ec290db27bcec6c26c2229c574aab10c6f0d0fbd067
- document type
- citation
- dois
- 10.1200/JCO.22.01273
- electronic publication date
- display
- 2022 Oct 7
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36206505
- immutable id
- pubmed:36206505@11fc9a96eaa32971f84b3ec290db27bcec6c26c2229c574aab10c6f0d0fbd067
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 508-516
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36206505
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- 5bcbd4c0e85e2dd0a19b4785238577c1996d8579af4779684d5c578818f9f481
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Jan 20
- precision
- day
- year
- 2023
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
Preserved source evidence · Not medical advice